Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage

Brunella Grigolo, Livia Roseti, Mauro Fiorini, Anna Piacentini, Luciana De Franceschi, Andrea Facchini

Research output: Contribution to journalArticle

Abstract

The clinical need for improved human autologous chondrocyte transplantation has motivated the use of different biomaterials, which are aimed at fixing the cells in the defect area and permit their proliferation and differentiation. The maintenance of the original phenotype by isolated chondrocytes grown in vitro is an important requisite for their use in repairing damaged articular cartilage. The methods to verify the expression of cartilage-specific molecules usually involve destructive procedures to recover the cells from the scaffolds for tests. The aim of our study was to find a soluble marker able to attest the occurrence of a differentiation process by chondrocytes grown onto a biomaterial used for cell transplantation. We turned our attention to cathepsin B which is known to be abnormally synthesized in de-differentiated chondrocytes and scarcely produced in the differentiated ones. The production of cathepsin B by human articular chondrocytes expanded in vitro and then grown onto a hyaluronan-based polymer derivative (Hyaff®-11) three-dimensional scaffold was evaluated with a specific enzyme-immunoassay at different experimental times together with the expression of mRNA by real-time PCR. We showed that cathepsin B, which is abundantly produced by chondrocytes grown in a monolayer culture, decreases significantly after the cells are seeded onto the scaffold, giving further evidence of a re-differentiation process. This result suggests cathepsin B a practical soluble marker to evaluate the "good" quality of transplantable constructs.

Original languageEnglish
Pages (from-to)1751-1757
Number of pages7
JournalBiomaterials
Volume24
Issue number10
DOIs
Publication statusPublished - May 2003

Fingerprint

Cathepsin B
Cartilage
Chondrocytes
Scaffolds
Biocompatible Materials
Biomaterials
Hyaluronic Acid
Scaffolds (biology)
Monolayers
Polymers
Enzymes
Autologous Transplantation
Cell Transplantation
Articular Cartilage
Derivatives
Immunoenzyme Techniques
Messenger RNA
Defects
Molecules
Cathepsins

Keywords

  • Cathepsin B
  • Chondrocytes
  • Hyaff®-11
  • Real-time PCR

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. / Grigolo, Brunella; Roseti, Livia; Fiorini, Mauro; Piacentini, Anna; De Franceschi, Luciana; Facchini, Andrea.

In: Biomaterials, Vol. 24, No. 10, 05.2003, p. 1751-1757.

Research output: Contribution to journalArticle

Grigolo, Brunella ; Roseti, Livia ; Fiorini, Mauro ; Piacentini, Anna ; De Franceschi, Luciana ; Facchini, Andrea. / Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. In: Biomaterials. 2003 ; Vol. 24, No. 10. pp. 1751-1757.
@article{11076101f24d4cf485ac57beae65b96a,
title = "Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage",
abstract = "The clinical need for improved human autologous chondrocyte transplantation has motivated the use of different biomaterials, which are aimed at fixing the cells in the defect area and permit their proliferation and differentiation. The maintenance of the original phenotype by isolated chondrocytes grown in vitro is an important requisite for their use in repairing damaged articular cartilage. The methods to verify the expression of cartilage-specific molecules usually involve destructive procedures to recover the cells from the scaffolds for tests. The aim of our study was to find a soluble marker able to attest the occurrence of a differentiation process by chondrocytes grown onto a biomaterial used for cell transplantation. We turned our attention to cathepsin B which is known to be abnormally synthesized in de-differentiated chondrocytes and scarcely produced in the differentiated ones. The production of cathepsin B by human articular chondrocytes expanded in vitro and then grown onto a hyaluronan-based polymer derivative (Hyaff{\circledR}-11) three-dimensional scaffold was evaluated with a specific enzyme-immunoassay at different experimental times together with the expression of mRNA by real-time PCR. We showed that cathepsin B, which is abundantly produced by chondrocytes grown in a monolayer culture, decreases significantly after the cells are seeded onto the scaffold, giving further evidence of a re-differentiation process. This result suggests cathepsin B a practical soluble marker to evaluate the {"}good{"} quality of transplantable constructs.",
keywords = "Cathepsin B, Chondrocytes, Hyaff{\circledR}-11, Real-time PCR",
author = "Brunella Grigolo and Livia Roseti and Mauro Fiorini and Anna Piacentini and {De Franceschi}, Luciana and Andrea Facchini",
year = "2003",
month = "5",
doi = "10.1016/S0142-9612(02)00569-0",
language = "English",
volume = "24",
pages = "1751--1757",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage

AU - Grigolo, Brunella

AU - Roseti, Livia

AU - Fiorini, Mauro

AU - Piacentini, Anna

AU - De Franceschi, Luciana

AU - Facchini, Andrea

PY - 2003/5

Y1 - 2003/5

N2 - The clinical need for improved human autologous chondrocyte transplantation has motivated the use of different biomaterials, which are aimed at fixing the cells in the defect area and permit their proliferation and differentiation. The maintenance of the original phenotype by isolated chondrocytes grown in vitro is an important requisite for their use in repairing damaged articular cartilage. The methods to verify the expression of cartilage-specific molecules usually involve destructive procedures to recover the cells from the scaffolds for tests. The aim of our study was to find a soluble marker able to attest the occurrence of a differentiation process by chondrocytes grown onto a biomaterial used for cell transplantation. We turned our attention to cathepsin B which is known to be abnormally synthesized in de-differentiated chondrocytes and scarcely produced in the differentiated ones. The production of cathepsin B by human articular chondrocytes expanded in vitro and then grown onto a hyaluronan-based polymer derivative (Hyaff®-11) three-dimensional scaffold was evaluated with a specific enzyme-immunoassay at different experimental times together with the expression of mRNA by real-time PCR. We showed that cathepsin B, which is abundantly produced by chondrocytes grown in a monolayer culture, decreases significantly after the cells are seeded onto the scaffold, giving further evidence of a re-differentiation process. This result suggests cathepsin B a practical soluble marker to evaluate the "good" quality of transplantable constructs.

AB - The clinical need for improved human autologous chondrocyte transplantation has motivated the use of different biomaterials, which are aimed at fixing the cells in the defect area and permit their proliferation and differentiation. The maintenance of the original phenotype by isolated chondrocytes grown in vitro is an important requisite for their use in repairing damaged articular cartilage. The methods to verify the expression of cartilage-specific molecules usually involve destructive procedures to recover the cells from the scaffolds for tests. The aim of our study was to find a soluble marker able to attest the occurrence of a differentiation process by chondrocytes grown onto a biomaterial used for cell transplantation. We turned our attention to cathepsin B which is known to be abnormally synthesized in de-differentiated chondrocytes and scarcely produced in the differentiated ones. The production of cathepsin B by human articular chondrocytes expanded in vitro and then grown onto a hyaluronan-based polymer derivative (Hyaff®-11) three-dimensional scaffold was evaluated with a specific enzyme-immunoassay at different experimental times together with the expression of mRNA by real-time PCR. We showed that cathepsin B, which is abundantly produced by chondrocytes grown in a monolayer culture, decreases significantly after the cells are seeded onto the scaffold, giving further evidence of a re-differentiation process. This result suggests cathepsin B a practical soluble marker to evaluate the "good" quality of transplantable constructs.

KW - Cathepsin B

KW - Chondrocytes

KW - Hyaff®-11

KW - Real-time PCR

UR - http://www.scopus.com/inward/record.url?scp=0037404356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037404356&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(02)00569-0

DO - 10.1016/S0142-9612(02)00569-0

M3 - Article

C2 - 12593957

AN - SCOPUS:0037404356

VL - 24

SP - 1751

EP - 1757

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 10

ER -